Orchestra BioMed

Orchestra BioMed is a biomedical innovation company established in 2017 and based in New Hope, Pennsylvania. The company is dedicated to developing therapeutic solutions for major medical conditions, with a primary emphasis on cardiovascular diseases, which account for approximately 31% of global deaths. Orchestra BioMed utilizes a partnership-driven business model, collaborating with medical device companies to facilitate the commercialization of its products. Key product candidates include BackBeat Cardiac Neuromodulation Therapy for managing hypertension and Virtue Sirolimus AngioInfusion Balloon for treating atherosclerotic artery disease. Through these efforts, Orchestra BioMed aims to accelerate the delivery of high-impact medical technologies to patients.

David P. Hochman

Co-Founder, CEO and Chairman

Andrew Taylor

CFO

1 past transactions

Vivasure Medical

Series D in 2022
Vivasure Medical Limited is a medical device company based in Galway, Ireland, focused on the research, development, and manufacturing of arterial and venous closure devices utilizing its proprietary PerQseal technology. The company specializes in creating polymer implants and delivery systems aimed at facilitating minimally invasive vessel closures in cardiology, interventional radiology, and vascular surgery. Its flagship product is an absorbable patch-based large-bore percutaneous closure device, specifically designed to close large arteriotomies during transcatheter procedures like transcatheter aortic valve replacement and endovascular aneurysm repair. Established in 2008, Vivasure Medical aims to enhance patient outcomes in vascular access procedures through innovative medical solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.